Capricor Therapeutics CAPR
NASDAQ CAPR
$8.94 -0.53 (-5.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Change in Interest Receivables (2013 - 2014)

Updated

Capricor Therapeutics (CAPR) reported Change in Interest Receivables of $593.00 for Q3 2014, compared with -$11,292 a year earlier.

Analysis

Capricor Therapeutics (CAPR) Change in Interest Receivables (2013 - 2014) Analysis & Trends

Over the twelve months ended Sep 30, 2014, Capricor Therapeutics' Change in Interest Receivables came in at -$2,604; for FY2013, it was -$25,028.

  • By year, Change in Interest Receivables came in at $25,215 in FY2012.
  • Per Business Quant data, the three quarters before Q3 2014 came in at -$527.00 (Q2 2014), $570.00 (Q1 2014) and -$3,240 (Q4 2013).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 593.00
Jun 30, 2014 -527.00
Mar 31, 2014 570.00
Dec 31, 2013 -3,240.00
Sep 30, 2013 -11,292.00
Jun 30, 2013 -2,222.00
Mar 31, 2013 -8,274.00
API Access

Capricor Therapeutics Change in Interest Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-interest-receivables&ticker=CAPR&period=max&api_key=YOUR_API_KEY